Evolus PE Ratio 2016-2018 | EOLS
Current and historical p/e ratio for Evolus (EOLS) from 2016 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evolus PE ratio as of March 22, 2019 is 0.00.
|Evolus PE Ratio Historical Data
||TTM Net EPS
||Medical Products Manufacturing
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.